IL262875B - Methods of regulation of galactosylation profiles of recombinant proteins - Google Patents

Methods of regulation of galactosylation profiles of recombinant proteins

Info

Publication number
IL262875B
IL262875B IL262875A IL26287518A IL262875B IL 262875 B IL262875 B IL 262875B IL 262875 A IL262875 A IL 262875A IL 26287518 A IL26287518 A IL 26287518A IL 262875 B IL262875 B IL 262875B
Authority
IL
Israel
Prior art keywords
methods
recombinant proteins
modulating protein
protein galactosylation
profiles
Prior art date
Application number
IL262875A
Other languages
English (en)
Hebrew (he)
Other versions
IL262875A (en
Inventor
David Bruhlmann
Martin Jordan
Herve Broly
Gabrielle Leclercq
Jonathan Souquet
Original Assignee
Ares Trading Sa
David Bruhlmann
Martin Jordan
Herve Broly
Gabrielle Leclercq
Jonathan Souquet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa, David Bruhlmann, Martin Jordan, Herve Broly, Gabrielle Leclercq, Jonathan Souquet filed Critical Ares Trading Sa
Publication of IL262875A publication Critical patent/IL262875A/en
Publication of IL262875B publication Critical patent/IL262875B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL262875A 2016-05-10 2018-11-08 Methods of regulation of galactosylation profiles of recombinant proteins IL262875B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16169062 2016-05-10
PCT/EP2017/061181 WO2017194605A1 (en) 2016-05-10 2017-05-10 Methods for modulating protein galactosylation profiles of recombinant proteins using peracetyl galactose

Publications (2)

Publication Number Publication Date
IL262875A IL262875A (en) 2018-12-31
IL262875B true IL262875B (en) 2022-05-01

Family

ID=56026651

Family Applications (1)

Application Number Title Priority Date Filing Date
IL262875A IL262875B (en) 2016-05-10 2018-11-08 Methods of regulation of galactosylation profiles of recombinant proteins

Country Status (9)

Country Link
US (1) US11118208B2 (https=)
EP (1) EP3455363B1 (https=)
JP (1) JP6882339B2 (https=)
CN (1) CN109072273B (https=)
AU (2) AU2017264541A1 (https=)
CA (1) CA3022769A1 (https=)
ES (1) ES2908067T3 (https=)
IL (1) IL262875B (https=)
WO (1) WO2017194605A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3397282A4 (en) 2015-12-30 2019-08-07 Momenta Pharmaceuticals, Inc. METHODS RELATING TO BIOLOGICA
WO2018119142A1 (en) 2016-12-21 2018-06-28 Amgen Inc. Anti-tnf alpha antibody formulations
AU2019336148B2 (en) 2018-09-06 2025-08-14 Momenta Pharmaceuticals, Inc. Methods of continuous cell culture
WO2020142275A1 (en) * 2018-12-31 2020-07-09 Momenta Pharmaceuticals, Inc. Methods of producing ustekinumab
CN113549667A (zh) * 2021-07-21 2021-10-26 杭州奕安济世生物药业有限公司 一种降低抗体半乳糖基化的方法
AU2023223660A1 (en) * 2022-02-25 2024-08-01 Kashiv Biosciences, Llc A process for improving polypeptide expression in mammalian cell culture
CN121058875A (zh) * 2025-10-11 2025-12-05 广东海洋大学 一种负载脂溶性多酚的碱诱导糖基化罗非鱼蛋白水解物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8163551B2 (en) * 2008-05-02 2012-04-24 Seattle Genetics, Inc. Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
DK2608796T3 (en) * 2010-08-05 2019-03-18 Seattle Genetics Inc Inhibition of protein fucosylation in vivo using fucose analogues
WO2015115849A1 (ko) * 2014-01-29 2015-08-06 주식회사 엘지생명과학 배양배지의 최적화를 통한 재조합 단백질의 갈락토오스화를 조절하는 방법
US20160039924A1 (en) * 2014-08-05 2016-02-11 Abbvie Inc. Methods for modulating the glycosylation profile of recombinant proteins using dissolved oxygen

Also Published As

Publication number Publication date
ES2908067T3 (es) 2022-04-27
JP2019514411A (ja) 2019-06-06
US20190153497A1 (en) 2019-05-23
JP6882339B2 (ja) 2021-06-02
CA3022769A1 (en) 2017-11-16
EP3455363A1 (en) 2019-03-20
AU2021258023A1 (en) 2021-11-25
AU2021258023B2 (en) 2023-11-16
US11118208B2 (en) 2021-09-14
WO2017194605A1 (en) 2017-11-16
EP3455363B1 (en) 2021-12-08
CN109072273A (zh) 2018-12-21
CN109072273B (zh) 2022-04-15
IL262875A (en) 2018-12-31
AU2017264541A1 (en) 2018-12-13

Similar Documents

Publication Publication Date Title
IL262875B (en) Methods of regulation of galactosylation profiles of recombinant proteins
ZA202006604B (en) Method for selection of high m6p recombinant proteins
EP3307297A4 (en) METHODS AND POLYPEPTIDES FOR MODULATION OF AN IMMUNE RESPONSE
SG11201802870RA (en) Modulation of gene expression and screening for deregulated protein expression
EP3236772A4 (en) Methods of purifying recombinant proteins
IL263342A (en) A method for stabilizing proteins
HUP1500363A2 (en) Method for increasing the galactose content of recombinant proteins
EP3101120A4 (en) Method for controlling galactosylation of recombinant protein through optimization of culture medium
IL249131A0 (en) A method for reducing the immunogenicity of protein and peptide
GB2591194B (en) Modulation of gene expression and screening for deregulated protein expression
EP3453763A4 (en) CONSTRUCTION OF GENETICALLY MODIFIED BACTERIA FOR HIGH EXPRESSION OF RECOMBINANT HUMAN SERUM ALBUMIN
IL254765A0 (en) A method for the monomerization of recombinant antibody molecules
EP3491006A4 (en) PROCESS FOR THE PREPARATION OF PROTEINS OR PEPTIDES
LT3818078T (lt) Rekombinantinių baltymų gamybos būdas
ZA201806508B (en) Direct infrared analysis of post-translational modification of proteins
EP3532618A4 (en) SIGNAL POLYPEPTIDES FOR IMPROVED PROTEIN SECRETION
EP3345003A4 (en) IDENTIFICATION OF PROTEINS IN THE ABSENCE OF PEPTIDE IDENTIFICATION
IL238101A (en) Method for making n - noble peptides, polypeptides and proteins
EP3183359A4 (en) Efficient selectivity of recombinant proteins
EP3628681A4 (en) METHODS TO EXTEND THE HALF-LIFE OF PROTEIN
IL265297A (en) Methods for regulating production profiles of recombinant proteins
EP3535403A4 (en) MODULATION OF PROTEIN ACCUMULATION AND ASSOCIATED USES
IL249610A (en) Chimeric proteins for cancer treatment
IL256707B (en) A method for the production of recombinant proteins
IL256706B (en) A method for making recombinant proteins